pubmed-article:8789865 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8789865 | lifeskim:mentions | umls-concept:C0039005 | lld:lifeskim |
pubmed-article:8789865 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
pubmed-article:8789865 | lifeskim:mentions | umls-concept:C0007546 | lld:lifeskim |
pubmed-article:8789865 | lifeskim:mentions | umls-concept:C0015409 | lld:lifeskim |
pubmed-article:8789865 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
pubmed-article:8789865 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:8789865 | pubmed:dateCreated | 1996-12-9 | lld:pubmed |
pubmed-article:8789865 | pubmed:abstractText | A swine model of penetrating ocular trauma was used to determine the delivery of systemically administered cefazolin to the vitreous cavity of traumatized and nontraumatized eyes. | lld:pubmed |
pubmed-article:8789865 | pubmed:language | eng | lld:pubmed |
pubmed-article:8789865 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8789865 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8789865 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8789865 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8789865 | pubmed:issn | 0275-004X | lld:pubmed |
pubmed-article:8789865 | pubmed:author | pubmed-author:WinterL WLW | lld:pubmed |
pubmed-article:8789865 | pubmed:author | pubmed-author:AlfaroD VDV | lld:pubmed |
pubmed-article:8789865 | pubmed:author | pubmed-author:MossS TST | lld:pubmed |
pubmed-article:8789865 | pubmed:author | pubmed-author:LaughlinR MRM | lld:pubmed |
pubmed-article:8789865 | pubmed:author | pubmed-author:NossovP CPC | lld:pubmed |
pubmed-article:8789865 | pubmed:author | pubmed-author:MichaudM EME | lld:pubmed |
pubmed-article:8789865 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8789865 | pubmed:volume | 16 | lld:pubmed |
pubmed-article:8789865 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8789865 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8789865 | pubmed:pagination | 246-9 | lld:pubmed |
pubmed-article:8789865 | pubmed:dateRevised | 2006-12-15 | lld:pubmed |
pubmed-article:8789865 | pubmed:meshHeading | pubmed-meshheading:8789865-... | lld:pubmed |
pubmed-article:8789865 | pubmed:meshHeading | pubmed-meshheading:8789865-... | lld:pubmed |
pubmed-article:8789865 | pubmed:meshHeading | pubmed-meshheading:8789865-... | lld:pubmed |
pubmed-article:8789865 | pubmed:meshHeading | pubmed-meshheading:8789865-... | lld:pubmed |
pubmed-article:8789865 | pubmed:meshHeading | pubmed-meshheading:8789865-... | lld:pubmed |
pubmed-article:8789865 | pubmed:meshHeading | pubmed-meshheading:8789865-... | lld:pubmed |
pubmed-article:8789865 | pubmed:meshHeading | pubmed-meshheading:8789865-... | lld:pubmed |
pubmed-article:8789865 | pubmed:meshHeading | pubmed-meshheading:8789865-... | lld:pubmed |
pubmed-article:8789865 | pubmed:meshHeading | pubmed-meshheading:8789865-... | lld:pubmed |
pubmed-article:8789865 | pubmed:meshHeading | pubmed-meshheading:8789865-... | lld:pubmed |
pubmed-article:8789865 | pubmed:year | 1996 | lld:pubmed |
pubmed-article:8789865 | pubmed:articleTitle | Intravenous cefazolin in penetrating eye injuries. A swine model. | lld:pubmed |
pubmed-article:8789865 | pubmed:affiliation | Walter Reed Army Institute of Research, Washington, District of Columbia, USA. | lld:pubmed |
pubmed-article:8789865 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:8789865 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |